AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice

This publication has 44 references indexed in Scilit:

• Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient Mice
  The American Journal of Pathology, 2011
• Phenotyping Cardiac Gene Therapy in Mice
  2010
• Gender influences cardiac function in the mdx model of duchenne cardiomyopathy
  Muscle & Nerve, 2010
• Cardiac Gene Therapy: Optimization of Gene Delivery Techniques In Vivo
  Human Gene Therapy, 2010
• Systemic Trans -Splicing Adeno-Associated Viral Delivery Efficiently Transduces the Heart of Adult mdx Mouse, a Model for Duchenne Muscular Dystrophy
  Human Gene Therapy, 2009
• Cardiac Expression of a Mini-dystrophin That Normalizes Skeletal Muscle Force Only Partially Restores Heart Function in Aged Mdx Mice
  Molecular Therapy, 2009
• Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice
  Human Molecular Genetics, 2009
• Adeno-Associated Virus Serotype-9 Microdystrophin Gene Therapy Ameliorates Electrocardiographic Abnormalities in mdx Mice
  Human Gene Therapy, 2008
• Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic mdx Mice
  Molecular Therapy, 2008
• Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007